SCHEMBL5427277

SCHEMBL5427277

C[N+](C)(C)C[C@@H](CC(=O)O)OC(=O)CC(O)C(=O)[O-]

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ CYP1A2 P05177 4/20 0.56
▸ MEN1 O00255 5/20 0.55
▸ KMT2A Q03164 5/20 0.55
▸ MAPK1 P28482 4/20 0.55
▸ MAPT P10636 4/20 0.55
▸ GMNN O75496 3/20 0.55
▸ NPSR1 Q6W5P4 3/20 0.55
▸ TP53 P04637 3/20 0.55
▸ TSHR P16473 3/20 0.55
▸ HSP90AA1 P07900 2/20 0.55
▸ BLM P54132 2/20 0.55
▸ NR1H4 Q96RI1 2/20 0.55
▸ CYP2C9 P11712 2/20 0.55
▸ HIF1A Q16665 2/20 0.55
▸ CYP2C19 P33261 2/20 0.54
▸ RECQL P46063 1/20 0.54
▸ GLA P06280 1/20 0.54
▸ PMP22 Q01453 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15813909 1.00 LMNA (0.57) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL28581905 0.86 LMNA (0.58) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL27906323 0.86 LMNA (0.58) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL16915065 0.84 LMNA (0.57) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL3193491 0.83 LMNA (0.64) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL5085300 0.83 LMNA (0.55) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL19923321 0.82 LMNA (0.62) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL20742884 0.82 LMNA (0.62) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL28916570 0.82 LMNA (0.62) LMNASMN1; SMN2CYP1A2MEN1KMT2A
SCHEMBL19923320 0.82 LMNA (0.62) LMNASMN1; SMN2CYP1A2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117384248-A Supermolecule acetyl hexapeptide-8 and preparation method thereof 懿奈(上海)生物科技有限公司 2024-01-12 — — CN claimed
CN-115710533-A Method for extracting wormwood essential oil from supramolecular L-carnitine malate NADES (sodium acetyldes) solvent 深圳市昭德健康科技有限公司 2023-02-24 — — CN claimed
CN-102018655-B Transdermal medicament delivery combined preparation NANOMED SKINCARE INC 2014-04-23 — — CN claimed
CN-102018655-A Transdermal drug delivery combined preparation CHINESE ACAD TECH INST PHYSICS 2011-04-20 — — CN claimed
US-20070072910-A1 Compositions and methods for lowering plasma concentrations of low density lipoproteins in humans NEXGEN PHARMA, INC. 2007-03-29 — — US claimed
CN-117603278-A Method for extracting alkaloid from coptis chinensis by using deep eutectic solvent of L-carnitine and application of method 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) 2024-02-27 — — CN disclosed
CN-117384248-A Supermolecule acetyl hexapeptide-8 and preparation method thereof 懿奈(上海)生物科技有限公司 2024-01-12 — — CN disclosed
CN-115710533-A Method for extracting wormwood essential oil from supramolecular L-carnitine malate NADES (sodium acetyldes) solvent 深圳市昭德健康科技有限公司 2023-02-24 — — CN disclosed
CN-115710533-A Method for extracting wormwood essential oil from supramolecular L-carnitine malate NADES (sodium acetyldes) solvent 深圳市昭德健康科技有限公司 2023-02-24 — — CN disclosed
CN-115710533-A Method for extracting wormwood essential oil from supramolecular L-carnitine malate NADES (sodium acetyldes) solvent 深圳市昭德健康科技有限公司 2023-02-24 — — CN disclosed
WO-2022095337-A1 L-CARNITINE-BASED EMULSION AND PREPARATION METHOD AND DRUG 哈尔滨工业大学(深圳) 2022-05-12 — — WO disclosed
CN-112370423-B L-carnitine-based emulsion, preparation method and medicine 哈尔滨工业大学(深圳) 2021-08-03 — — CN disclosed
CN-112370423-A L-carnitine-based emulsion, preparation method and medicine 哈尔滨工业大学(深圳) 2021-02-19 — — CN disclosed
CN-102018655-B Transdermal medicament delivery combined preparation NANOMED SKINCARE INC 2014-04-23 — — CN disclosed
CN-102018655-A Transdermal drug delivery combined preparation CHINESE ACAD TECH INST PHYSICS 2011-04-20 — — CN disclosed
US-20070072910-A1 Compositions and methods for lowering plasma concentrations of low density lipoproteins in humans NEXGEN PHARMA, INC. 2007-03-29 — — US disclosed
Send feedback